Skip to content

ScienceNot yet confirmed elsewhere1 publisher2 min readPublished

CDC finds 8.5% of 2023 US Shigella samples resisted five common antibiotics

The CDC reported in April 2026 that 8.5 percent of 2023 US Shigella samples resisted five common antibiotics, up from zero in 2011 through 2015. Because the infection mimics food poisoning, a sexual history can decide which treatment works.

The Scientist · Science desk

How we use AISend a correction

Illustration accompanying CDC finds 8.5% of 2023 US Shigella samples resisted five common antibiotics
Generated illustration

What happened

  • The CDC counted 510 extensively drug-resistant isolates among the nearly 17,000 US Shigella samples collected between 2011 and October 2023.
  • Among the 258 patients whose hospitalization status was recorded, about four in ten had been admitted, and the report recorded no deaths.
  • A July study in The Lancet Infectious Diseases found UK strains tied to sexual transmission spread farther and formed more infection chains than other locally acquired strains.
  • In the US samples where age and sex were recorded, most patients were adult men.

Compiled by The ScientistSomething wrong?How this is made

Why it matters

  • constraint The US data cannot show how much of the resistant rise is sexual spread: case records rarely noted sexual contact, and some of the increase may come from changes in testing.
  • decision For severe or persistent diarrhea, a recent sexual history can change which test a clinician orders and which antibiotic they try.
  • exposure Someone who feels better can still shed Shigella for up to two weeks, so the CDC advises waiting two weeks after diarrhea ends before sex.
  • precedent UK health authorities advise anyone diagnosed with Shigella to be screened for other sexually transmitted infections.

Shigella is a gut infection. It spreads when tiny amounts of fecal matter reach the mouth, which during sex can happen through direct contact or on hands [9]. Most people recover without antibiotics; the resistance matters only for the minority who need treatment [10].

Measured across the whole collection period, the extensively-drug-resistant share is about 3 percent: 510 of the nearly 17,000 US samples gathered since 2011 [11][24]. The 8.5 percent for 2023 is the recent, higher slice.

The sexual-transmission signal comes from the UK. A study published in July in The Lancet Infectious Diseases, led by Cambridge's Kate Baker, examined more than 3,500 Shigella sonnei samples collected between 2004 and 2020 [2][3]. The team could not confirm how any individual was infected, so it counted men aged 16 to 60 with no recent travel to higher-risk regions as likely sexual transmission [4]. The route is inferred from age, sex and travel, not confirmed case by case.

"This is multiple overlapping variants emerging that are all quickly becoming resistant to the drugs we use to treat them," Baker said in a press release [17]. She added: "It's highly likely that if you contracted your Shigella through sex you require different treatment to someone who contracted it through travel" [18].

The study also connected Shigella's resistance to how gonorrhea is treated. In a person carrying both infections, an antibiotic given for the gonorrhea can kill the Shigella that are susceptible to it and leave the resistant ones to spread, an effect the authors call bystander resistance [19]. The clearest evidence came from a change in policy: when UK guidelines stopped recommending azithromycin for gonorrhea, Shigella strains resistant to azithromycin lost some of their spreading advantage [20].

What to watch

  • Whether US case records start capturing sexual history, which would let surveillance measure the sexual-transmission rate directly.
  • Whether US treatment guidance begins to differ by likely route of infection, as Baker suggests it should.
  • Whether other countries see their gonorrhea prescribing reflected in Shigella resistance, as the UK azithromycin change was.

Clarity's read

What the record supports and how the coverage leans. The claims behind it follow.

Reality

Evidence55
Adoption
Insufficient
Hype gap+25
Incentives
Insufficient
Confidence50
Why these scores

Claim ledger

Ranked by verification strength, evidence, and original report placement.

  1. [1]

    A July study in The Lancet Infectious Diseases found that in the U.K., strains linked to sexual transmission spread farther and formed more chains of infection than other homegrown strains.

  2. [2]

    The Cambridge team looked at more than 3,500 Shigella sonnei samples collected in the U.K. between 2004 and 2020.

  3. [3]

    Kate Baker is the senior author of the U.K. study.

Sources

1 independent publisher whose own reporting we read for this story.

  1. discovermagazine.com

    1 article · October 9, 2026

    A Diarrhea-Causing Bacterium Spread Through Sex is Resisting Five Common Antibiotics

Share your take

Let Clarity write the post for you.

Signed-in readers get a short post drafted on this story in the register they choose — narrative, analytical, or a direct position — editable to the last word before it goes anywhere. The share buttons at the top of this story work without an account.

Topics and entities

Follow any of these and your For You feed starts watching them — no settings page required.

Entities

Loading related stories